In this issue:
Abatacept vs adalimumab in early RA
Initiating TNF inhibitor therapy in AS
Myofascial inflammation in recent-onset polymyalgia rheumatica
Cardiovascular safety of tocilizumab vs etanercept in RA
Infliximab vs adalimumab for refractory uveitis due to Behçet’s disease
Secukinumab for enthesitis in PsA
Exacerbation of pulmonary comorbidities after abatacept vs TNF inhibitors
Tocilizumab monotherapy for polymyalgia rheumatica
Canakinumab in adult familial Mediterranean fever
Ixekizumab in active radiographic axial spondyloarthritis
Ixekizumab vs adalimumab in biological-naive active PsA
Biologics and pregnancy
Predictors of response to golimumab in active PsA
Please login below to download this issue (PDF)